Publication:
Do xenogeneic anti-HLA-A3 antibody cause antibody-mediated rejection in kidney transplant?

dc.contributor.coauthorUstaakgül, Sebahat
dc.contributor.coauthorTemurhan, Sonay
dc.contributor.coauthorÇınar, Çiğdem Kekik
dc.contributor.coauthorÇiftçi, Hayriye Şentürk
dc.contributor.coauthorBayraktar, Adem
dc.contributor.coauthorUçar, Ali Rıza
dc.contributor.coauthorBakkaloğlu, Hüseyin
dc.contributor.coauthorTürkmen, Aydın
dc.contributor.coauthorSavranoğuz, Fatma
dc.contributor.departmentTIREX (Koç University Transplant Immunology Research Centre of Excellence)
dc.contributor.kuauthorDemir, Erol
dc.date.accessioned2024-12-29T09:40:06Z
dc.date.issued2024
dc.description.abstractObjective: Anti-thymocyte globulin-Fresenius is used for induction treatment in kidney transplantation. The antibody ofrabbit originated against human leukocyte antigen A3 were demonstrated in the serum of patients who used anti-thymocyte globulin-Fresenius. We investigated whether anti-human leukocyte antigen A3 antibodies detected due to anti-thymocyte globulin administration had any effect on patient and allograft survival in short- and long-term follow-up. Methods: Fifty-one patients who underwent kidney transplantation between 2004 and 2014 were included in the study. Twenty-nine patients who underwent transplantation from deceased donors received an induction therapy consisting of anti-thymocyte globulin-Fresenius. Antibodies against the human leukocyte antigen were identified using the LABScreen panel reactive antibody class I/II kits with the Luminex method. The graft function and loss, patient survival, and the presence of acute/chronic rejection were investigated. Results: Anti-human leukocyte antigen A3 antibody was detected in 41.3% of the patients receiving anti-thymocyte globulin induction (P = .001). This antibody disappeared at 234.4 days posttransplant. No difference was found regarding pretransplant and posttransplant sensitization of the patients who had posttransplant anti-human leukocyte antigen A3 positivity. The anti-thymocyte globulin dose and administration period were similar for anti-human leukocyte antigen A3 antibody-positive and -negative patients (P >.05). There was no significant difference between groups in short-term, first year, and long-term results of serum creatinine, estimated glomerular filtration rate, and proteinuria values (P >.05). Conclusion: We demonstrated that xenogeneic anti-human leukocyte antigen A3 antibody could be detected in posttrans-plant serum of patients receiving anti-thymocyte globulin induction independent of the dose and duration. The development of this antibody was independent of the exposure of the patient to pre- and posttransplant sensitizing event or the presence of human leukocyte antigen A3 in the allograft. While this study did not demonstrate the effect of xenogeneic anti-human leukocyte antigen A3 antibody on graft and patient survival, retrospective multicenter cohort studies are needed on this issue
dc.description.indexedbyWoS
dc.description.indexedbyTR Dizin
dc.description.issue1
dc.description.publisherscopeNational
dc.description.volume33
dc.identifier.doi10.1016/j.jmaa.2024.128204
dc.identifier.eissn2667-4440
dc.identifier.quartileQ4
dc.identifier.urihttps://doi.org/10.1016/j.jmaa.2024.128204
dc.identifier.urihttps://hdl.handle.net/20.500.14288/23192
dc.identifier.wos1186182000019
dc.keywordsAnti-thymocyte globulin-fresenius
dc.keywordsXenogeneic anti-HLA-A3 antibody
dc.keywordsAntibody-mediated rejection
dc.languageen
dc.publisherAVES
dc.sourceTurkish Journal of Nephrology
dc.subjectUrology and nephrology
dc.titleDo xenogeneic anti-HLA-A3 antibody cause antibody-mediated rejection in kidney transplant?
dc.typeJournal article
dspace.entity.typePublication
local.contributor.kuauthorDemir, Erol
local.publication.orgunit1Graduate School of Health Sciences
local.publication.orgunit2TIREX (Koç University Transplant Immunology Research Centre of Excellence)
relation.isOrgUnitOfPublication29cd9ca5-6407-4582-92b6-788bc6f33efd
relation.isOrgUnitOfPublication.latestForDiscovery29cd9ca5-6407-4582-92b6-788bc6f33efd

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
IR04562.pdf
Size:
658.67 KB
Format:
Adobe Portable Document Format